Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Availability of New Drugs and Americans' Ability to Work

This work examined the extent to which the introduction of new drugs has increased society's ability to produce goods and services by increasing the number of hours worked per member of the working-age population. Under very conservative assumptions, the estimates indicated that the value of the increase in ability to work attributable to new drugs is 2.5 times as great as expenditure on new drugs.

The study also found that the potential of medicines to increase employee productivity should be considered in the design of drug-reimbursement policies. Conversely, policies that broadly reduce the development and utilization of new drugs may ultimately reduce our ability to produce other goods and services.

Due to copyright issues, this study is only available through the JOEM website.

Newsletter Volume

E.V.I.dently June 2014

Message from NPCValue-Based Insurance Design and Specialty Medications: Shifting the Focus from “How Much” We Spend to “How Well” We SpendAccess to...
Blog Post

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

Earlier this week, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, spoke at the Bundled Payments Summit in...
Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Newsletter Volume

E.V.I.dently February 2014

Message From NPCAs PCORI Funds Head-to-Head Comparisons, Research Must Remain Meaningful, TransparentIn the years since its establishment, the...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research

WASHINGTON, DC (September 11, 2012)—A new set of principles developed by a group of leading researchers could help to ensure more consistency in how...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals

WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Commentary and Testimony Page

Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making

The number of voices in the comparative effectiveness research (CER) conversation is continuing to grow, but not all stakeholders have the same...
Commentary and Testimony Page

Comparative Effectiveness Research and the Changing Health Care Landscape

This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...
Commentary and Testimony Page

CER: Who Can Say What, and When Can They Say It?

With billions of dollars in comparative effectiveness research (CER) set for completion in coming years, there will be broader discussions about the...
Commentary and Testimony Page

CER Done Right: Why It Matters

The health care reform law is aimed at reshaping the health care landscape through the creation of many new regulations and regulatory...
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
YouTube Videos

PCORI Outlines Efforts to Engage Patients

Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...
Blog Post

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

Earlier this week, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, spoke at the Bundled Payments Summit in...
Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Blog Post

#TBT: Bob Costas, Presenteeism and Its Impact on Productivity

As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous...
Blog Post

The Role of Pharmaceuticals in Health Insurance Exchanges

As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...

Research

2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

NPC's 2013 survey shows that health care stakeholders have growing expectations for the use of...

Communicating About Comparative Effectiveness Research: A Health Affairs Symposium on the Issues

One of many issues connected with comparative effectiveness research is how the findings will be...

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...
  •  
  • 1 of 38
  • >

Commentary & Testimony